Description
Mircera 75mcg/0.3ml Injection – Single Dose
Mircera 75mcg/0.3ml is a prescription injectable medication used primarily to treat anemia associated with chronic kidney disease (CKD). It contains methoxy polyethylene glycol-epoetin beta, a long-acting erythropoiesis-stimulating agent (ESA) that helps increase red blood cell production, improving oxygen delivery throughout the body.
This single-dose prefilled syringe contains 75mcg of active ingredient in 0.3ml solution, designed for subcutaneous or intravenous administration under medical supervision. Mircera works by stimulating the bone marrow to produce red blood cells, effectively managing anemia symptoms such as fatigue, weakness, and shortness of breath.
Mircera is typically prescribed for patients with chronic kidney disease who require treatment to maintain adequate hemoglobin levels. The long-acting formulation allows for less frequent dosing compared to traditional ESAs, improving patient convenience and adherence.
Administration and dosage must be strictly guided by a healthcare professional, with regular monitoring of hemoglobin levels to adjust treatment as needed. Potential side effects include injection site reactions, hypertension, or headache.
Mircera 75mcg/0.3ml offers an effective and reliable treatment option for managing anemia in CKD patients, supporting improved quality of life and overall health when used under appropriate medical guidance.
Reviews
There are no reviews yet.